Daniel Abdun-Nabi Insider Trading Transactions
Get free email notifications about insider trading for Daniel Abdun-Nabi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel Abdun-Nabi. Daniel Abdun-Nabi is CEO in Emergent BioSolutions Inc. ($EBS) and Chief Executive Officer in Emergent BioSolutions Inc. ($EBS) and President & CEO in Emergent BioSolutions Inc. ($EBS) and President and CEO in Emergent BioSolutions Inc. ($EBS) and SVP Corp Aff, GC & Secretary in Emergent BioSolutions Inc. ($EBS) and SVP, Corp Aff, GC & Secretary in Emergent BioSolutions Inc. ($EBS) and in REGENXBIO Inc. ($RGNX) and Director in REGENXBIO Inc. ($RGNX) and Board of Directors in Aptevo Therapeutics Inc. ($APVO) and Director in Aptevo Therapeutics Inc. ($APVO).
Latest Insider Trading Transactions of Daniel Abdun-Nabi
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APVO, EBS, RGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
Jun 25 2019 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Board of Directors | Buy | P | 0.90 | 16,667 | 15,000 | 109,351 | 92.7 K to 109.4 K (+17.98 %) |
Jun 04 2019 | RGNX | REGENXBIO Inc. | Abdun-Nabi Daniel | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
Jun 04 2019 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Board of Directors | Option Exercise | A | 0.73 | 25,000 | 18,125 | 25,000 | |
Mar 04 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Sell | S | 58.11 | 14,565 | 846,328 | 142,617 | 157.2 K to 142.6 K (-9.27 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 58.71 | 5,101 | 299,480 | 157,182 | 162.3 K to 157.2 K (-3.14 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 57.98 | 2,570 | 149,009 | 162,283 | 164.9 K to 162.3 K (-1.56 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 61.01 | 1,714 | 104,571 | 164,853 | 166.6 K to 164.9 K (-1.03 %) |
Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Option Exercise | M | 13.38 | 1,319 | 17,648 | 0 | |
Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Option Exercise | M | 13.38 | 28,220 | 377,584 | 1,319 | |
Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Sell | S | 65.00 | 1,319 | 85,735 | 166,567 | 167.9 K to 166.6 K (-0.79 %) |
Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Buy | M | 13.38 | 1,319 | 17,648 | 167,886 | 166.6 K to 167.9 K (+0.79 %) |
Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Sell | S | 65.00 | 28,220 | 1,834,300 | 166,567 | 194.8 K to 166.6 K (-14.49 %) |
Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Buy | M | 13.38 | 28,220 | 377,584 | 194,787 | 166.6 K to 194.8 K (+16.94 %) |
Sep 06 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Option Exercise | M | 13.38 | 60,000 | 802,800 | 29,539 | |
Sep 06 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Sell | S | 59.49 | 30,776 | 1,830,944 | 166,567 | 197.3 K to 166.6 K (-15.60 %) |
Sep 06 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Sell | S | 60.54 | 60,000 | 3,632,286 | 197,343 | 257.3 K to 197.3 K (-23.32 %) |
Sep 06 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Buy | M | 13.38 | 60,000 | 802,800 | 257,343 | 197.3 K to 257.3 K (+30.40 %) |
Jun 07 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | Chief Executive Off ... | Sell | S | 52.11 | 15,785 | 822,615 | 197,343 | 213.1 K to 197.3 K (-7.41 %) |
Jun 04 2018 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 5.49 | 25,000 | 137,250 | 25,000 | |
May 30 2018 | RGNX | REGENXBIO Inc. | Abdun-Nabi Daniel | Option Exercise | A | 49.45 | 12,500 | 618,125 | 12,500 | ||
Mar 13 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 51.84 | 7,825 | 405,648 | 213,128 | 221 K to 213.1 K (-3.54 %) |
Jan 04 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 14.44 | 21,906 | 316,323 | 0 | |
Jan 04 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 47.91 | 21,906 | 1,049,516 | 204,134 | 226 K to 204.1 K (-9.69 %) |
Jan 04 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 14.44 | 21,906 | 316,323 | 226,040 | 204.1 K to 226 K (+10.73 %) |
Dec 14 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 14.44 | 20,000 | 288,800 | 21,906 | |
Dec 14 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 45.99 | 20,000 | 919,800 | 204,134 | 224.1 K to 204.1 K (-8.92 %) |
Dec 14 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 14.44 | 20,000 | 288,800 | 224,134 | 204.1 K to 224.1 K (+9.80 %) |
Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 14.44 | 20,000 | 288,800 | 41,906 | |
Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 22.03 | 11,508 | 253,521 | 0 | |
Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 42.92 | 20,000 | 858,400 | 204,134 | 224.1 K to 204.1 K (-8.92 %) |
Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 14.44 | 20,000 | 288,800 | 224,134 | 204.1 K to 224.1 K (+9.80 %) |
Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 42.50 | 11,508 | 489,090 | 204,134 | 215.6 K to 204.1 K (-5.34 %) |
Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 22.03 | 11,508 | 253,521 | 215,642 | 204.1 K to 215.6 K (+5.64 %) |
Sep 29 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 22.03 | 15,000 | 330,450 | 11,508 | |
Sep 29 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 39.92 | 15,000 | 598,770 | 204,134 | 219.1 K to 204.1 K (-6.85 %) |
Sep 29 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 22.03 | 15,000 | 330,450 | 219,134 | 204.1 K to 219.1 K (+7.35 %) |
Sep 05 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 22.03 | 15,000 | 330,450 | 26,508 | |
Sep 05 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 37.21 | 15,000 | 558,150 | 204,134 | 219.1 K to 204.1 K (-6.85 %) |
Sep 05 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 22.03 | 15,000 | 330,450 | 219,134 | 204.1 K to 219.1 K (+7.35 %) |
Jun 01 2017 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 2.15 | 12,500 | 26,875 | 12,500 | |
May 26 2017 | RGNX | REGENXBIO Inc. | Abdun-Nabi Daniel | Director | Option Exercise | A | 18.85 | 12,500 | 235,625 | 12,500 | |
Mar 10 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 31.05 | 10,738 | 333,415 | 204,134 | 214.9 K to 204.1 K (-5.00 %) |
Mar 10 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 30.98 | 8,226 | 254,841 | 214,872 | 223.1 K to 214.9 K (-3.69 %) |
Mar 02 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | A | 30.63 | 78,329 | 2,399,217 | 78,329 | |
Mar 02 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 30.63 | 6,184 | 189,416 | 223,098 | 229.3 K to 223.1 K (-2.70 %) |
Mar 02 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Grant | A | 0.00 | 19,589 | 0 | 229,282 | 209.7 K to 229.3 K (+9.34 %) |
Mar 02 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Grant | A | 0.00 | 19,588 | 0 | 209,693 | 190.1 K to 209.7 K (+10.30 %) |
Mar 01 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 14.51 | 3,662 | 53,136 | 0 | |
Mar 01 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 30.63 | 984 | 30,140 | 190,105 | 191.1 K to 190.1 K (-0.51 %) |
Mar 01 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 30.63 | 1,735 | 53,143 | 191,089 | 192.8 K to 191.1 K (-0.90 %) |
Mar 01 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 30.63 | 3,662 | 112,167 | 192,824 | 189.2 K to 192.8 K (+1.94 %) |
Jan 12 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President and CEO | Option Exercise | M | 14.51 | 38,006 | 551,467 | 3,662 | |
Jan 12 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President and CEO | Option Exercise | J | 14.51 | 3,662 | 53,136 | 41,668 | |
Jan 12 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President and CEO | Sell | S | 31.28 | 28,240 | 883,296 | 189,162 | 217.4 K to 189.2 K (-12.99 %) |
Jan 12 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President and CEO | Buy | M | 14.51 | 38,006 | 551,467 | 217,402 | 179.4 K to 217.4 K (+21.19 %) |
Jan 12 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President and CEO | Buy | J | 0.00 | 3,419 | 0 | 179,396 | 176 K to 179.4 K (+1.94 %) |
Jan 12 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President and CEO | Buy | J | 0.00 | 3,032 | 0 | 175,977 | 172.9 K to 176 K (+1.75 %) |
Jan 12 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President and CEO | Buy | J | 0.00 | 1,979 | 0 | 172,945 | 171 K to 172.9 K (+1.16 %) |
Aug 09 2016 | RGNX | REGENXBIO Inc. | Abdun-Nabi Daniel | Director | Option Exercise | A | 8.69 | 25,000 | 217,250 | 25,000 | |
Aug 09 2016 | RGNX | REGENXBIO Inc. | Abdun-Nabi Daniel | Director | Option Exercise | A | 8.69 | 25,000 | 217,250 | 25,000 | |
Aug 09 2016 | RGNX | REGENXBIO Inc. | Abdun-Nabi Daniel | Director | Option Exercise | A | 8.69 | 25,000 | 217,250 | 25,000 | |
Aug 05 2016 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 2.94 | 18,750 | 55,125 | 18,750 | |
Jun 03 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 43.74 | 8,699 | 380,494 | 170,966 | 179.7 K to 171 K (-4.84 %) |
May 24 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 42.00 | 8,701 | 365,442 | 179,665 | 188.4 K to 179.7 K (-4.62 %) |
Apr 05 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 34.22 | 6,493 | 222,190 | 197,068 | 203.6 K to 197.1 K (-3.19 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 34.38 | 9,794 | 336,718 | 203,561 | 213.4 K to 203.6 K (-4.59 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 34.60 | 7,484 | 258,946 | 213,355 | 220.8 K to 213.4 K (-3.39 %) |
Mar 03 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | A | 33.83 | 70,922 | 2,399,291 | 70,922 | |
Mar 03 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Grant | A | 0.00 | 35,471 | 0 | 220,839 | 185.4 K to 220.8 K (+19.14 %) |
Apr 20 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 40.17 | 2,373 | 95,323 | 188,366 | 190.7 K to 188.4 K (-1.24 %) |
Apr 20 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 40.17 | 3,580 | 143,809 | 190,739 | 194.3 K to 190.7 K (-1.84 %) |
Apr 20 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 40.17 | 2,749 | 110,427 | 194,319 | 197.1 K to 194.3 K (-1.39 %) |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 18.90 | 22,855 | 431,960 | 0 | |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 18.90 | 40,354 | 762,691 | 22,855 | |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 39.17 | 22,855 | 895,230 | 185,368 | 208.2 K to 185.4 K (-10.98 %) |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 18.90 | 22,855 | 431,960 | 208,223 | 185.4 K to 208.2 K (+12.33 %) |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 38.99 | 40,354 | 1,573,402 | 185,368 | 225.7 K to 185.4 K (-17.88 %) |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 18.90 | 40,354 | 762,691 | 225,722 | 185.4 K to 225.7 K (+21.77 %) |
Dec 17 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 24.15 | 4,140 | 99,981 | 37,860 | |
Dec 17 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 37.87 | 2,641 | 100,015 | 185,368 | 188 K to 185.4 K (-1.40 %) |
Dec 17 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 24.15 | 4,140 | 99,981 | 188,009 | 183.9 K to 188 K (+2.25 %) |
May 15 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Gift | G | 0.00 | 936 | 0 | 183,869 | 184.8 K to 183.9 K (-0.51 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | A | 28.99 | 94,344 | 2,735,033 | 94,344 | |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 28.67 | 4,490 | 128,728 | 184,805 | 189.3 K to 184.8 K (-2.37 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 28.99 | 6,493 | 188,232 | 189,295 | 195.8 K to 189.3 K (-3.32 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 29.00 | 9,779 | 283,591 | 195,788 | 205.6 K to 195.8 K (-4.76 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Grant | A | 0.00 | 47,188 | 0 | 205,567 | 158.4 K to 205.6 K (+29.79 %) |
Dec 15 2006 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | SVP, Corp Aff, GC & ... | Option Exercise | A | 10.13 | 42,000 | 425,460 | 42,000 | |
Nov 21 2006 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | SVP Corp Aff, GC & ... | Option Exercise | C | 2.74 | 106,452 | 291,678 | 106,452 | |
Nov 21 2006 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | SVP Corp Aff, GC & ... | Option Exercise | C | 2.74 | 106,452 | 291,678 | 0 |
Page: 1